Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 AND SODIUM CHLORIDE 0 33 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
Head-to-head clinical analysis: DEXTROSE 5 AND SODIUM CHLORIDE 0 33 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE.
DEXTROSE 5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that provides caloric support and is metabolized to carbon dioxide and water, yielding energy. Sodium chloride provides electrolyte replacement and maintains osmotic pressure.
Magnesium sulfate acts as a physiological calcium channel blocker. It inhibits calcium influx into presynaptic nerve terminals, reducing acetylcholine release at the neuromuscular junction and decreasing muscle contraction. It also antagonizes NMDA receptors and stabilizes neuronal membranes.
Intravenous infusion. Adult dose is typically 100-200 mL/hour, adjusted based on fluid and electrolyte needs, serum glucose, and clinical status.
IV: Loading dose 4-6 g over 20-30 minutes, followed by maintenance infusion 1-2 g/hour for seizure prophylaxis in severe preeclampsia/eclampsia. IM: 4-8 g deep IM initially, then 4 g every 4 hours as needed.
None Documented
None Documented
Clinical Note
moderateMagnesium sulfate + Gatifloxacin
"The serum concentration of Gatifloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Rosoxacin
"The serum concentration of Rosoxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateMagnesium sulfate + Levofloxacin
"The serum concentration of Levofloxacin can be decreased when it is combined with Magnesium sulfate."
Clinical Note
moderateDextrose has an effective half-life of approximately 1.5-2 hours for equilibration with total body water; however, the terminal elimination half-life is not applicable as it is rapidly metabolized. Sodium has a elimination half-life of about 24-48 hours depending on renal function.
Terminal elimination half-life approximately 4-6 hours in patients with normal renal function; prolonged to 12-24 hours or more in renal impairment, necessitating dose adjustment
The dextrose is metabolized to carbon dioxide and water, with negligible renal excretion of unchanged dextrose. Sodium and chloride are excreted renally, with >90% of an administered sodium load eliminated via kidneys within 24-48 hours in patients with normal renal function.
Primarily renal (90-95% as unchanged drug); minor biliary/fecal (<5%)
Category A/B
Category C
Electrolyte
Electrolyte
Magnesium sulfate + Trovafloxacin
"The serum concentration of Trovafloxacin can be decreased when it is combined with Magnesium sulfate."